Document is current
Any future updates will be listed below
-
Authors
Rothwell, Joshua
Payne, Nicholas
Kilburn-Toppin, Fleur
Huang, Yuan
Kaggie, Joshua
Black, Richard
Hickman, Sarah
Kasmai, Bahman
Juette, Arne
Gilbert, Fiona
-
Funding
Funding for this research was provided by:
Future Dreams Breast Cancer Charity
National Institute for Health and Care Research (NIHR) Cambridge Biomedical Research Centre (NIHR203312*)
Cancer Research UK early detection program grant (C543/A26884)
- License Information
-
More Information
Article History
Received: 7 October 2025
Accepted: 20 February 2026
First Online: 8 March 2026
Competing interests
: J.R., N.R.P., S.E.H. and F.J.G. research agreements with Merantix, ScreenPoint Medical, Lunit, iCAD, Google, Therapixel and Volpara. S.E.H. Radiology Artificial Intelligence Trainee Editorial Board member. J.R. and F.KT. were supported by a Future Dreams breast cancer charity grant awarded to F.J.G. F.KT. consulting for Genesis Care. J.D.K. research support from the NIHR Cambridge Biomedical Research Centre and the Wellcome Trust; grants from Cancer Research UK, AstraZeneca, and GE HealthCare. F.J.G., recipient of the Cancer Research UK Early Detection Programme grant; consulting for Alphabet and Kheiron; honoraria for lectures from GE HealthCare; participation on an advisory board for Bayer; past president (2020–2022) of the European Society of Breast Imaging; current Clinical Radiology AI Lead Advisor at the Royal College of Radiologists; contrast media for unrelated trial from Bayer. Y.H., R.T.B., B.K. and A.J. have no competing interests to declare.
